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ABSTRACT
Background: Whereas several epidemiological studies suggest that low dietary intake of vit-
amins C and E is linked to increased hip fracture in smokers and antioxidants (dietary and
endogenous) are reduced in elderly osteoporotic women, none has demonstrated an effect of
supplemental antioxidants on bone turnover.
Methods: In an observational study of 533 randomly selected women, we investigated the
associations among the use of antioxidant supplements, vitamins C and E, serum levels of
biochemical markers of bone turnover (C-telopeptide [CTx] and bone-specific alkaline phos-
phatase [BSAP]), and whole body bone mineral density (BMD).
Results: Twenty-two women were identified as current users of supplemental vitamin C or
E. Duration of antioxidant supplement use was negatively associated with age-adjusted and
weight-adjusted serum CTx, such that mean CTx levels (natural log transformed) were 0.022
units lower for each year of exposure. No significant differences were detected for adjusted
serum BSAP or whole body BMD.
Conclusions: Our results suggest that antioxidant vitamin E or C supplements may suppress
bone resorption in nonsmoking postmenopausal women. Coupling of bone formation and re-
sorption may explain the absence of an effect on bone formation markers, given evidence of
enhanced effects of antioxidants on osteoblast differentiation; this warrants further investi-




OXIDATIVE STRESS IS CAUSED BY exposure to ox-idants that disrupt the reduction/oxidation
(redox) status of cells. This process plays an im-
portant role in aging and has been implicated in
the pathogenesis of degenerative diseases, includ-
ing cancer,1 diabetes mellitus,2 atherosclerosis,3
neurodegenerative diseases,4 and rheumatoid
arthritis.5 Osteoporosis is a common degenera-
1The University of Melbourne, Department of Clinical and Biomedical Sciences, Barwon Health, Geelong, Victo-
ria, Australia.
2Alfred Pathology Service, Alfred Hospital, and Monash University, Department of Medicine, Melbourne, Victo-
ria, Australia.
This work was supported by the Victorian Health Promotion Foundation and the Geelong Region Medical Re-
search Foundation.
6100_10_p295-300  4/5/06  1:28 PM  Page 295
tive disease, yet there is limited evidence that it
is characterized by oxidative stress.
Antioxidants attenuate the cytotoxic effects of
oxidative stress by reducing reactive oxygen
species (ROS) and other intracellular free radicals.
Vitamins C and E function as antioxidant vita-
mins as they possess free radical-scavenging
properties. Lower levels of these dietary and
endogenous antioxidants have been found in el-
derly osteoporotic women compared with age-
matched controls.6 Several epidemiological stud-
ies have found a positive association between
dietary vitamin C intake and bone mineral den-
sity (BMD) in postmenopausal women,7–9 and
low dietary intake of vitamins C and E has been
linked to an increased risk of hip fracture in
smokers.10
BMD and bone turnover are independent pre-
dictors of fracture risk.11 Guinea pig studies have
shown that low vitamin C intake in growing
animals is associated with high rates of bone
turnover.12 Low intake of vitamin C has been as-
sociated with an increased rate of bone loss in
postmenopausal women13; however, data con-
cerning bone turnover in humans is lacking. We
sought to evaluate the associations between the
use of antioxidant supplements vitamins C and E
and serum levels of biochemical markers of bone




This community-based study is set in the Bar-
won Statistical Division surrounding Geelong in
southeastern Australia and forms part of the
Geelong Osteoporosis Study.14 From a total of
872 women randomly selected from electoral
rolls, 816 over the age of 48 years were included
in this analysis (median age 68.3 years, range
48–89 years). Fifty-six women were excluded be-
cause no blood sample was available for bio-
chemical analysis. We have reported previously
that the mean age of menopause for women liv-
ing in the region is 48 years,14 and we used this
as the minimum age for inclusion in the study.
This study was approved by the Barwon Health
Research and Ethics Advisory Committee. Writ-
ten informed consent was obtained from all par-
ticipants.
Data
Self-reported supplement and medication use,
diet, and lifestyle were documented by ques-
tionnaire. Subjects were described as antioxidant
supplement users if they were current users of
vitamins C or E or both at the time of assess-
ment. Duration of use was documented in years,
but doses remained unspecified. Calcium intake
was estimated from a validated food frequency
questionnaire.15 Subjects were described as ac-
tive if they reported at least “walking at brisk
pace, performing normal housework or other
work, and engaging in light exercise” on a reg-
ular basis; otherwise, they were described as
sedentary. Blood samples were obtained after an
overnight fast and stored at 80°C for random
batch analysis. The serum bone resorption
marker, C-telopeptide (CTx), was measured us-
ing an electrochemiluminescence immunoassay
(Crosslaps, Roche, Germany), with an interassay
coefficient of variation (CV) of 8.5%. Serum
bone-specific alkaline phosphatase (BSAP), a
marker of bone formation, was calculated from
total alkaline phosphatase measured with a col-
orimetric assay (p-nitrophenyl phosphate with
AMP buffer, Roche, Mannheim, Germany) after
BSAP precipitation using wheat germ lectin as
recommended by the manufacturer. The in-
terassay CV was 11.3%. BMD was measured for
the whole body (Lunar DPX-L, software version
1.31) in 801 women, with a short-term precision
of 0.4%.
Statistics
Characteristics of supplement users and non-
users were compared using 2-sample t test or
Mann-Whitney for continuous and chi-square
test for discrete data. Women who were smokers
or users of hormone therapy (HT), bisphospho-
nates, calcitriol, oral glucocorticoids, calcium, or
vitamin D supplements were excluded from the
analyses investigating the association among an-
tioxidant vitamin supplement use, markers of
bone turnover, and BMD because of potential
confounding. Analysis of variance (ANOVA), fol-
lowed by the Tukey test of multiple comparisons,
was used to test for differences in unadjusted
serum bone turnover markers (serum CTx and
BSAP), with duration of exposure to antioxidant
vitamin supplements categorized into three
groups: 0, 5 years, and 5 years. Using contin-
uous data, standard multiple regression tech-
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niques were used to test the association among
duration of supplement use, markers of bone
turnover, and BMD. Both serum CTx and BSAP
were natural log transformed (lnCTx and lnB-
SAP) in the regression models. All statistical
analyses were performed using MINITAB (ver-
sion 13).
RESULTS
Characteristics of total sample
Forty-four subjects were identified as users of
vitamin C (n  26) and/or vitamin E (n  22),
representing 5.4% of our sample. Median dura-
tion of use among the antioxidant supplement
users was 4.0 years (interquartile range [IQR]
2.0–10.0). There were no differences in age, di-
etary calcium intakes, weight, or height between
the groups (all p  0.05); however, the supple-
mented group tended to have a lower body mass
index (BMI) (p  0.05). Unadjusted serum CTx
values tended to be lower among antioxidant
supplement users, but the difference was not sig-
nificant: median CTx (IQR), antioxidant users vs.
nonusers, 293 (163–490) vs. 376 (233–538) pg/mL,
p  0.1. No differences were observed for serum
BSAP or whole body BMD (p  0.05). There were
no differences in the proportions of women who
were smokers, physically active, or users of drugs
known to affect bone metabolism (HT, bisphos-
phonates, calcitriol), but more of the antioxidant
supplement users were also taking calcium or vi-
tamin D: (38.6% (n  17 of 44) vs. 11.8% (n  91
of 772), p  0.001. A small proportion (2.7%) of
nonsupplement users and none of the supple-
mented group used glucocorticoids.
Duration of antioxidant supplement use, 
bone turnover markers, and BMD
Further analyses were performed for 533 wo-
men after excluding the following potential con-
founders: smokers (n  78), users of HT, bisphos-
phonates, calcitriol, or glucocorticoids (n  159),
and users of calcium or vitamin D (n  108).
Characteristics of the antioxidant supplement
users and nonusers in the reduced group (n 
533) are compared in Table 1. Antioxidant sup-
plement users had lower weight and BMI.
Among antioxidant supplement users, 68% had
used them for 5 years, and 32% had used them
for 5 years. There was a pattern of decreasing
CTx (unadjusted) with increasing duration of ex-
posure (Fig. 1); CTx levels were lowest among
women who had used them for at least 5 years
(p  0.05). No pattern was observed for serum
BSAP or whole body BMD. Multiple regression
analysis showed that duration of antioxidant sup-
plement use was negatively associated with age-
adjusted and weight-adjusted serum CTx, such
that mean lnCTx levels were 0.022 units lower for
each year of exposure (Table 2). No significant
differences were detected for adjusted serum
BSAP or whole body BMD.
Serum markers of bone turnover were correlated
with each other and negatively correlated with
whole body BMD: lnCTx and lnBSAP, r  0.3;
lnCTx and BMD, r  0.4; lnBSAP and BMD, r 
0.2 (all p  0.001). Duration of antioxidant sup-
plement use was associated with BMD-adjusted
lnCTx (slope  0.047, duration year, BMD
g/cm2, p  0.003) but not with BMD-adjusted lnB-
SAP. Among women with the same BMD, serum
CTx levels were lower the longer the exposure to
antioxidant supplements.
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TABLE 1. CHARACTERISTICS OF ANTIOXIDANT SUPPLEMENT USERS AND NONUSERS: 
MEANS (SD), MEDIAN (INTERQUARTILE RANGE), OR PERCENTAGE (n)
Supplement users Nonusers
Characteristic n  22 n  511 p value
Age (yr) 75.1 (56.3–82.3) 71.1 (60.7–80.8) 0.6
Weight (kg) 62.7 ( 17.2) 68.7 ( 13.7) 0.05
Height (m) 157.9 ( 8.0) 157.6 ( 6.3) 0.9
BMI (kg/m2) 25.0 ( 5.7) 27.6 ( 5.2) 0.02
Dietary calcium (mg/day) 719 ( 366) 673 ( 362) 0.6
Active 36.4 (8) 48.1 (246) 0.3
CTx (pg/mL) 342 (216–603) 418 (279–571) 0.3
BSAP (U/L) 28 (20–36) 28 (20–37) 0.8
Whole body BMD (g/cm2) 1.04 ( 0.16) 1.06 ( 0.12) 0.6
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DISCUSSION
To our knowledge, this is the first study to in-
vestigate the association between the use of anti-
oxidant vitamin supplements and bone turnover in
postmenopausal women. Our results suggest that
use of vitamin C or E supplements is associated
with decreased levels of serum CTx, a marker of
bone resorption. No differences in serum levels of
the bone formation marker BSAP or whole body
BMD were detected. We observed that antioxidant
vitamin supplement use is associated with reduced
bone resorption in these women.
The close coupling of osteoclastic bone resorp-
tion and osteoblastic bone formation maintains
bone mass in healthy young adults; bone loss oc-
curs when resorption exceeds formation. In vitro
models demonstrate that ROS stimulate osteo-
clast differentiation16–18 and inhibit differentia-
tion of bone osteoblastic cells.19 Thus, it is feasi-
ble that antioxidants may reduce the damaging
effects of oxidative stress by reducing the upreg-
ulated osteoclastic differentiation and enhancing
the downregulated osteoblastic differentiation.
Our results suggest that antioxidant supplements
reduce bone resorption. It is likely that bone for-
mation would also be reduced through coupling,
and this, in conjunction with increased os-
teoblastic differentiation in the presence of an-
tioxidants, may result in no net change in serum
markers of bone formation, as reported in this
study. Further studies on the role of antioxidants
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FIG. 1. Unadjusted serum C-telopeptide (pg/mL), natural log transformed (lnCTx) (mean  SE), with increasing
duration of exposure to vitamin C or E supplements (a and b significantly different, p  0.05).
TABLE 2. MULTIPLE REGRESSION ANALYSIS WITH MARKERS OF BONE TURNOVER OR WHOLE BODY BMD AS DEPENDENT
VARIABLE AND DURATION OF ANTIOXIDANT VITAMIN SUPPLEMENT USE (IN YEARS) AS INDEPENDENT VARIABLE OF INTEREST
-coefficient
Variablea Adjustments (slope) p value
lnCTx Age, weight 0.022 0.05
lnBSAP Age 0.003 0.70
Whole body BMD Age, weight 0.001 0.60
aUnits: CTx, pg/mL; BSAP, U/L; BMD, g/cm2.
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in the regulation of both osteoclastic bone re-
sorption and osteoblastic bone formation are re-
quired to further explore this hypothesis.
Smoking is associated with increased levels of
oxidative stress. Cigarette smoke is a source of
free radicals and, moreover, can generate free
radicals in vivo.20 There is evidence to suggest 
that supplementation with antioxidants protects
smokers from oxidative damage.21 Serum con-
centrations of both vitamins C and E are gener-
ally lower in smokers than in nonsmokers,21,22
and the protection against oxidative damage af-
forded by supplementation is more pronounced
among smokers.22 Smoking is recognized as a risk
factor for bone loss and fragile bones.23,24 Smok-
ing alters the rate of bone turnover; cessation of
smoking causes a reduction in the bone resorp-
tion marker, N-telopeptide, in postmenopausal
women.24 For these reasons, smokers were ex-
cluded from our detailed analysis, but there is a
need to further explore, in a larger group, the hy-
pothesis that the detrimental effect of smoking on
bones is mediated through increased oxidative
stress and that antioxidants may reduce the neg-
ative effects of cigarette smoking on bone.
There are some limitations to our study. First
is the accuracy of self-reported antioxidant sup-
plement use because of the possibility of recall
bias and the potential irregularity of use. Second,
the participants were on a free diet, and we have
not analyzed dietary intakes of antioxidants.
Third, it is possible that some of the subjects
might have been deficient in antioxidant vita-
mins. Collagen cross-linking is reduced in vita-
min C deficiency; thus, vitamin C nutrition may
affect serum CTx concentrations.25 Fourth, in our
small study, no association was found between
supplement use and whole body BMD, but small
numbers may have limited our ability to detect
an association. With   0.05, we had 80% power
to detect differences of 9.8% for BMD. Thus, we
cannot exclude the possibility of a type II error.
The observed difference in bone resorption is
small, indicating that the antioxidant effect is
likely to be limited in its size. Finally, as with all
observational studies, our results could be biased
by unrecognized confounders. The supplement
users may be more health conscious, and al-
though the supplemented group tended to have
a lower BMI and a higher proportion were also
supplemented with calcium and vitamin D, we
detected no differences in dietary calcium intakes
or in levels of activity.
CONCLUSIONS
Among nonsmoking postmenopausal women,
we detected lower levels of the bone resorption
marker, CTx, with increased exposure to vitamins
C or E or both. Although no association was ob-
served with BMD, the hypothesis that antioxidant
supplements may suppress bone resorption war-
rants further investigation. This work adds to the
growing body of evidence that antioxidants may
play a role in preventing osteoporosis.
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